Register information Patent

DE file number : 60 2017 054 740.9 (Status: pending/in force, Query started: April 26, 2025)

Please note: This English version is a non-binding translation of the German register excerpt. Only the German version of the register excerpt is legally binding.

Master data
INIDCriterionFieldContent
Type of IP rightSARTPatent
StatusSTPending/in force
21DE file number DAKZ60 2017 054 740.9
96EP file numberEAKZ17 82 3018.1
86WO file numberWAKZPCT/EP2017/074907
97EP publication numberEPN3518933
87WO publication numberWPN2018060501
54Designation/titleTIVERFAHREN ZUR BEHANDLUNG VON GEBÄRMUTTERMYOMEN UND ENDOMETRIOSE
51IPC main classICM
(ICMV)
A61K 31/513 (2006.01)
51IPC secondary class(es)ICS
(ICSV)
A61K 31/565 (2006.01), A61K 31/57 (2006.01), A61P 15/00 (2006.01)
22DE application dateDATSep 29, 2017
96EP application dateEATSep 29, 2017
86WO application dateWATSep 29, 2017
43Date of first publicationOTApr 5, 2018
Date of publication of grantPETMar 16, 2022
71/73Applicant/ownerINHSumitomo Pharma Switzerland GmbH, Basel, CH; Takeda Pharmaceutical Company Limited, Osaka, JP
72InventorINJOHNSON, Brendan Mark, 27514 Chapel Hill North Carolina, US; SEELY, Lynn, San Mateo California, 94402, US; MUDD, JR., Paul N., Cary North Carolina 27519, US; WOLLOWITZ, Susan, Lafayette California 94549, US; HIBBERD, Mark, Liss Hampshire GU33 6NQ, GB; TANIMOTO, Masataka, Osaka-shi Osaka 540-8645, JP; RAJASEKHAR, Vijaykumar Reddy, Apple Valley California 92308, US; SUKHATME, Mayukh Vasant, New York New York, 10018, US
Address for service Marks & Clerk (Luxembourg) LLP, 1017 LUXEMBOURG, LU
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
201662402034 P
Sep 30, 2016
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
201662402055 P
Sep 30, 2016
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
201762528409 P
Jul 3, 2017
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
201762492839 P
May 1, 2017
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
201662402150 P
Sep 30, 2016
Due dateFT
FG
Sep 30, 2025
Annual fee for the 9th year Patent fees
Patent division in charge 44
97EP language of publicationELANGEN - Englisch
84Designated EP contracting statesEDSAL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Published EP/WO documentsEPWOPNOriginal document: EP000003518933A2
Searchable text: EP000003518933A2
Original document: EP000003518933B1
Searchable text: EP000003518933B1
Original document: EP000003518933B2
Searchable text: EP000003518933B2
Original document: WO002018060501
Searchable text: WO002018060501
43Date of first publicationEVTApr 5, 2018
Date of the first transfer into DPMAregisterEREGTAug 7, 2019
Date of the (most recent) update in DPMAregisterREGTMar 13, 2025
(Show all update days)(Hide all update days)
  • Mar 13, 2025
    • Procedures: Opposition procedure, Decision by EPO to maintain patent in amended form has become final, 26.02.2025: changed
  • Feb 6, 2025
    • Published EP/WO documents: changed
    • Procedures: Opposition procedure, Patent maintained in amended form by EPO, 26.02.2025: new
    • Procedures: Opposition procedure, Decision by EPO to maintain patent in amended form has become final, 26.02.2025: new
  • Oct 2, 2024
    • Due date: changed
  • Aug 8, 2024
    • Procedures: New applicant/owner details, New applicant/owner details, 03.07.2024: changed
  • Jul 4, 2024; May 29, 2024; Jan 4, 2024; Sep 29, 2023; Jan 5, 2023; Dec 22, 2022; Apr 15, 2022; Mar 23, 2022; Mar 1, 2022; Feb 24, 2022; Sep 30, 2021; Nov 7, 2019; Aug 23, 2019
    • Historical data not available for this/these date(s)
  • Aug 7, 2019
    • Date of the first transfer into DPMAregister
Procedural data
No.Kind of procedureLegal statusDate of legal/procedural statusPublication dateAlle Details anzeigen
1 Procedure relating to PCT application WO publication Apr 5, 2018  Details anzeigen
2 Procedure relating to EP application EPO 1st publication Aug 7, 2019  Details anzeigen
3 Publications Publication of a mention regarding EP 1st publication by DPMA Sep 19, 2019 Sep 19, 2019 Details anzeigen
4 Procedure relating to EP application EPO publication of mention regarding patent grant (beginning of opposition period) Mar 16, 2022  Details anzeigen
5 Publications Publication by DPMA of mention regarding EP patent grant Apr 7, 2022 Apr 7, 2022 Details anzeigen
6 Opposition procedure Opposition to patent filed Dec 15, 2022 Jan 26, 2023 Details anzeigen
7 New applicant/owner details New applicant/owner details Jul 3, 2024 Aug 8, 2024 Details anzeigen
8 Opposition procedure Patent maintained in amended form by EPO Feb 26, 2025  Details anzeigen
9 Opposition procedure Decision by EPO to maintain patent in amended form has become final Feb 26, 2025 Mar 13, 2025 Details anzeigen
View procedures Procedure relating to PCT application (No.: 1)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to PCT application
Legal/procedural statusVSTWO publication
Date of legal/procedural statusVSTTApr 5, 2018
Date of update of the procedureREGTFeb 24, 2022
View procedures Procedure relating to EP application (No.: 2)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO 1st publication
Date of legal/procedural statusVSTTAug 7, 2019
View procedures Publications (No.: 3)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication of a mention regarding EP 1st publication by DPMA
Date of legal/procedural statusVSTTSep 19, 2019
Issue numberHN38
YearPJ2019
Publication dateVTSep 19, 2019
Type of publicationPARTBibliographic data
View procedures Procedure relating to EP application (No.: 4)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO publication of mention regarding patent grant (beginning of opposition period)
Date of legal/procedural statusVSTTMar 16, 2022
Date of update of the procedureREGTFeb 24, 2022
View procedures Publications (No.: 5)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication by DPMA of mention regarding EP patent grant
Date of legal/procedural statusVSTTApr 7, 2022
Issue numberHN14
YearPJ2022
Publication dateVTApr 7, 2022
Type of publicationPARTBibliographic data
PartHTPart 5
Date of update of the procedureREGTMar 23, 2022
View procedures Opposition procedure (No.: 6)
INIDCriterionFieldContent Close details
Type of procedureVARTOpposition procedure
Legal/procedural statusVSTOpposition to patent filed
Date of legal/procedural statusVSTTDec 15, 2022
Issue numberHN4
YearPJ2023
Publication dateVTJan 26, 2023
Type of publicationPARTBibliographic data
PartHTPart 3
Date of update of the procedureREGTJan 5, 2023
View procedures New applicant/owner details (No.: 7)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTJul 3, 2024
Issue numberHN32
YearPJ2024
Publication dateVTAug 8, 2024
Type of publicationPARTBibliographic data
PartHTPart 3
71/73Applicant/ownerINHSumitomo Pharma Switzerland GmbH, Basel, CH; Takeda Pharmaceutical Company Limited, Osaka, JP
71/73Previous applicant/ownerINHFMyovant Sciences GmbH, Basel, CH, Takeda Pharmaceutical Company Limited, Osaka, JP
Date of update of the procedureREGTAug 8, 2024
View procedures Opposition procedure (No.: 8)
INIDCriterionFieldContent Close details
Type of procedureVARTOpposition procedure
Legal/procedural statusVSTPatent maintained in amended form by EPO
Date of legal/procedural statusVSTTFeb 26, 2025
Date of update of the procedureREGTFeb 6, 2025
View procedures Opposition procedure (No.: 9)
INIDCriterionFieldContent Close details
Type of procedureVARTOpposition procedure
Legal/procedural statusVSTDecision by EPO to maintain patent in amended form has become final
Date of legal/procedural statusVSTTFeb 26, 2025
Issue numberHN11
YearPJ2025
Publication dateVTMar 13, 2025
Type of publicationPARTBibliographic data
PartHTPart 3
Date of update of the procedureREGTMar 13, 2025